We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Anticoagulant and Antiplatelet Agents in Patients Undergoing Vitreoretinal Surgery

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01020656
First Posted: November 25, 2009
Last Update Posted: November 25, 2009
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Centre Hospitalier Universitaire Dijon
November 24, 2009
November 25, 2009
November 25, 2009
January 2009
June 2009   (Final data collection date for primary outcome measure)
Not Provided
Not Provided
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
Anticoagulant and Antiplatelet Agents in Patients Undergoing Vitreoretinal Surgery
Maintenance of Anticoagulant and Antiplatelet Agents for Patients Undergoing Vitreoretinal Surgery
Purpose: To establish the prevalence of anticoagulant, aspirin, and clopidogrel use in patients undergoing vitreoretinal surgery, and to compare the outcome of peribulbar anesthesia between users and non-users.
Not Provided
Observational
Observational Model: Cohort
Time Perspective: Retrospective
Not Provided
Not Provided
Non-Probability Sample
We analyzed the chart of 239 eyes (206 patients) which underwent posterior segment surgery with peribulbar anesthesia.
Retinal Detachment
Not Provided
  • group 1
    patients with no anticoagulants used as the control group
  • group 2
    patients treated with anticoagulant therapy (warfarin, fluindone, acenocoumarol)
  • group 3
    patients treated with aspirin
  • group 4
    patients treated with clopidogrel therapy
  • group 5
    patients treated with both anticoagulant and aspirin medications
  • group 6
    patients treated with both anticoagulant and clopidogrel medications
  • group 7
    patients treated with both aspirin and clopidogrel medications
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
206
June 2009
June 2009   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Take or no anticoagulant treatment before surgery,
  • Vitreoretinal surgery

Exclusion Criteria:none

  • No surgery
  • Anesthetic complication
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
France
 
 
NCT01020656
MARIE02
No
Not Provided
Not Provided
Professor Catherine Creuzot-Garcher, Centre Hospitalier Universitaire Dijon
Centre Hospitalier Universitaire Dijon
Not Provided
Not Provided
Centre Hospitalier Universitaire Dijon
November 2009